Personalized medicine: a new era in diagnostics and therapy
Committee on Biotechnology PAS ; Institute of Bioorganic Chemistry PAS
Monografia opublikowana w zeszycie Biotechnologia 2(85)'2009
Many commonly used drugs are typically effective in only 40-60% of the patient population, but still substantial number of subjects experience serious adverse reactions and death directly related to drug use. Personalized medicine uses genomic and molecular data to better target the delivery of healthcare by helping to determine individual patient’s response to certain therapies.
0860-7796 ; oai:rcin.org.pl:72133 ; IChB B-80
Library of Institute of Bioorganic Chemistry PAS
Creative Commons Attribution BY-SA 4.0 license
Institute of Bioorganic Chemistry of the Polish Academy of Science
Institute of Bioorganic Chemistry of the Polish Academy of Science
Oct 2, 2020
Jun 3, 2019
260
https://rcin.org.pl/publication/94548
Edition name | Date |
---|---|
Medycyna personalizowana - nowa era diagnostyki i farmakoterapii | Oct 2, 2020 |
Sławińska, Anna Siwek, Maria
Tyczewska, Agata Bąkowska- Żywicka, Kamila
Pieczyński, Marcin Bielewicz, Dawid Dolata, Jakub Szweykowska-Kulińska, Zofia
Broniarczyk, Justyna Koczorowska, Maria Magdalena Durzyńska, Julia Warowicka, Alicja Goździcka-Józefiak, Anna